The Department of Health and Human Services will commit $20 million this year and has options to provide up to $300 million over the next 10 years to combat antimicrobial resistant (AMR) infections, according to the agency Thursday.
The funding is part of the agency’s collaboration with the global nonprofit Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X).
This public-private partnership is dedicated to accelerating the early development of therapeutics, preventatives, and diagnostics for AMR infections, the HHS said.
“Antibiotic resistance continues to grow at an alarming rate worldwide, killing an estimated 1.27 million people each year and affecting the US and ...